M&A, private equity, venture capital, and public offerings
Loading M&A transactions...
DataPorium’s investment screener lets you explore deal activity in one place. Filter mergers and acquisitions, private equity, venture capital, and public offerings by company, date, and type to see where capital is moving — all in a fast, clean interface built for analysts and investors.
Deal activity is one of the clearest signals of where money and conviction are flowing. A wave of acquisitions in a sector often marks consolidation; a surge in venture funding points to an emerging theme; a busy IPO window reflects investor appetite for risk. The investment screener brings M&A, private equity, venture capital, and public offerings together so you can spot these patterns early. The same data is also available through the DataPorium financial data API.
To get the most from deal screening, filter by the companies, sectors, and timeframes relevant to your thesis, then watch how activity clusters over time. A company making repeated acquisitions may be building scale, while heavy private-equity interest can foreshadow a take-private. Pair these insights with the stock screener to connect corporate dealmaking back to the equities you follow.
It is a deal-activity screener that lets you filter mergers and acquisitions, private equity, venture capital, and public offerings by company, date, and deal type — all in one place.
Track M&A transactions, private equity and venture capital investments, and IPOs, then filter by the companies and timeframes that matter to your research.
Following deal activity reveals where capital is flowing, which sectors are consolidating, and how companies are growing through acquisition — context that pure price data alone cannot provide.
30 US IPOs raised $32.8 billion in Q3 2026, $26.5 billion of it from SK hynix. IPOs averaged a flat return and the IPO index fell 11.5%.
The largest deals announced in Q3 2026 were Prologis-SEGRO (about $18.8 billion), Aon-USI ($17.0 billion) and Uber-Delivery Hero ($14.8 billion).
How to read a merger announcement, using Boston Scientific and Penumbra in 2026: the premium, cash and stock terms, approvals, deadlines and break fees.